Sociodemographic and clinical predictors of depression in children and adolescents at clinical high-risk for psychosis: Results of a two-year follow-up study
Depressive disorders are a main cause of disability already in children and adolescents, in whom the clinical picture somewhat differs from adult-onset depression. Depression is also a frequent comorbidity in somatic and mental disorders and has been considered an actionable outcome for, for example, patients at clinical high-risk for psychoses (CHRP). Thus, we studied sociodemographic and clinical predictors of depression/dysthymia in an underage sample with focus on those considered at CHRP. Our baseline sample (N = 676) included CHR-P patients (n = 183), inpatients admitted for non-psychotic, non-affective disorders (n = 277), and community participants (n = 216) of age 8.0-17.9 years (43.8 % male). They were interviewed for mental disorders and symptoms with various instruments, including the Mini International Neuropsychiatric Interview for Children and Adolescents, which was also used to assess depression/dysthymia in the CHR-P group at one- and two-year-follow up (n = 117/73). Stepwise logistic regression analyses were used to first identify a cross-sectional baseline model in the complete sample that was then tested prospectively in CHR-P patients. The baseline model included nationality and 13 clinical variables, particularly mild depressive symptoms. Variables contributing significantly to the prediction of persistence or new occurrence of depression/dysthymia varied over time, indicating that depression/dysthymia in CHR-P minors may require different predictors depending on the follow-up time. Furthermore, the prospective accuracy of ruling out depression/dysthymia was superior to the accuracy of ruling it in. This lower positive likelihood ratio might be overcome in future by stepwise approaches that further stratify risk in those CHR-P minors identified as at increased risk of depression/dysthymia.
Authors
- Chantal Michel (ORCID: https://orcid.org/0000-0003-1165-6681)
- Marcel Romanos (ORCID: https://orcid.org/0000-0001-7628-8299)
- Rahel Flückiger (ORCID: https://orcid.org/0000-0003-1228-7267)
- Georg Romer (ORCID: https://orcid.org/0000-0002-4984-7822)
- Ellen Greimel (ORCID: https://orcid.org/0000-0002-9916-9230)
- Naweed Osman (ORCID: https://orcid.org/0000-0001-9761-0099)
- Frauke Schultze‐Lutter (ORCID: https://orcid.org/0000-0003-1956-9574)
- Gerd Schulte‐Körne (ORCID: https://orcid.org/0000-0002-9960-1572)
- Petra Walger
- Mauricia Franscini
- Benno G. Schimmelmann (ORCID: https://orcid.org/0000-0002-8980-1466)
- Nina Traber‐Walker
- Volker Reißner (ORCID: https://orcid.org/0000-0002-8066-6368)
- Nick Styss
- Eva Meisenzahl (ORCID: https://orcid.org/0009-0006-9007-3159)
Institutions
- University of Bern (CH)
- Universität Hamburg (DE)
- University of Zurich (CH)
- University of Münster (DE)
- University of Würzburg (DE)
- Düsseldorf University Hospital (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Heinrich Heine University Düsseldorf (DE)
- FH Münster University of Applied Sciences (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Journal of Affective Disorders
- Published
- 2025-04-12
- DOI
- https://doi.org/10.1016/j.jad.2025.04.002
- Citations
- 1
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Deutsche Forschungsgemeinschaft
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung